Kenneth Lynard

Kenneth Lynard is a seasoned financial executive currently serving as Managing Director & Group CFO at Schoeller Allibert since 2024. Prior to this role, Kenneth held key positions at Zentiva as Board Member & Group CFO, where significant achievements included driving transformation and growth for a leading pan-European pharmaceutical company. At Affidea, Kenneth was Managing Director & Group CFO, steering the largest European medical services operator in advanced diagnostics and cancer care. Kenneth's earlier experience at Gilead Sciences as SVP & CFO involved overseeing substantial revenue growth in biopharmaceuticals and managing a substantial team of professionals. Kenneth's professional history also includes notable roles in major companies such as Medtronic and Coloplast, along with a solid educational background featuring an EMBA from IMD and a Master's in Business Economics & Auditing from Copenhagen Business School.